New award for palliative care research

A research project into palliative care, led by Anne Lanceley of the UCL Institute for Women's Health, has been awarded a £25,000 grant from national charity Target Ovarian Cancer. It is one of three grants to be awarded as part of the charity's medical research programme, a unique nationwide funding scheme specifically targeted at ovarian cancer research. Lanceley will use the award to fund the UK arm of an international project, led by Professor Michael Friedlander for the Australian & New Zealand Gynaecological Oncology Group (ANZGOG). The project will investigate whether chemotherapy can be successfully used for symptom relief in ovarian cancer patients. In total it will involve 800 patients from 11 countries and without this funding UK patients would be unable to take part. Lanceley says: "I am delighted with the funding from Target Ovarian Cancer which enables us to deliver the UK arm of a study of such global significance to women's health and end of life care. Women often experience a lot of distressing symptoms at the later stages of their ovarian cancer illness and the majority will have palliative chemotherapy.
account creation

TO READ THIS ARTICLE, CREATE YOUR ACCOUNT

And extend your reading, free of charge and with no commitment.

Register


Login

Your Benefits

  • Access to all content
  • Receive newsmails for news and jobs
  • Post ads

myScience